Abstract:
In the high HIV prevalence countries of southern Africa, co-infection with HIV and Tuberculosis (TB) is a common and increasing threat, not only to people living with HIV (PLHIV), but to all communities living in poverty and in conditions of poor hygiene, under-nourishment and over crowding. The article analyses how TB affects people and its most effective treatment-the Mycobacterium vaccae (MV).
